Alberta Health Services Says Advisory Group Notes Problems With Ivermectin Studies


Alberta Health Services says its science advisory group has updated its review of the use of ivermectin to treat COVID-19, warning that existing studies are problematic and available evidence does not deem it safe.

The province’s health-care delivery agency said in a series of tweets that studies to date on the use of ivermectin, which is primarily used to treat cases of worms in livestock, on the novel coronaviruses have “inadequate controls” and a “flawed design”.

The agency also notes that existing studies suffer from bias and small sample sizes, and some of those previously shared have also been withdrawn due to concerns about fraudulent data.

It says more research is needed to determine the safety and effectiveness of ivermectin in the prevention or treatment of COVID-19.

The agency issued a warning about the dangers of ivermectin on Friday after a Vancouver doctor said in a social media post he used the drug to treat three COVID-19 patients while filling a rural hospital in Rimbey, Alta. last month.

He says there remains considerable uncertainty as to whether there is a benefit with ivermectin, but there are known drawbacks.

“We urge the public not to abuse drugs in their efforts to avoid or manage COVID-19,” the health agency said in its tweets on Saturday.

“Vaccination remains our best way to prevent COVID-19 at this time. “

The agency said it would conduct a review after receiving complaints about the doctor, but he is not expected to work as a replacement in Alberta’s healthcare system again.

Calls have also increased to the Alberta Poison and Drug Information Service regarding ivermectin.

This report by The Canadian Press was first published on October 9, 2021.


About Author

Leave A Reply